FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Media coverage

• Title	FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery
  Media name/outlet	BioSpace
  Country/Territory	United States
  Date	9/04/25
  URL	https://www.biospace.com/press-releases/fda-grants-seastar-medical-two-new-breakthrough-device-designations-for-scd-therapy-to-treat-systemic-inflammatory-response-in-adult-and-pediatric-patients-undergoing-cardiac-surgery
  Persons	Kevin Chung